PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $790,000 | +12.1% | 250,900 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $705,000 | +12.4% | 242,200 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $627,000 | -13.2% | 222,400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $722,000 | +47.6% | 222,400 | -1.8% | 0.00% | 0.0% |
| Q3 2019 | $489,000 | -42.7% | 226,500 | -16.6% | 0.00% | 0.0% |
| Q2 2019 | $853,000 | -13.8% | 271,700 | +2.1% | 0.00% | 0.0% |
| Q1 2019 | $990,000 | +32.7% | 266,100 | +3.5% | 0.00% | 0.0% |
| Q4 2018 | $746,000 | +5.4% | 257,100 | -4.5% | 0.00% | 0.0% |
| Q3 2018 | $708,000 | +12.4% | 269,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $630,000 | -20.4% | 269,200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $791,000 | +7.2% | 269,200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $738,000 | -11.9% | 269,200 | +8.9% | 0.00% | 0.0% |
| Q3 2017 | $838,000 | +37.2% | 247,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $611,000 | +8.9% | 247,200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $561,000 | +7.1% | 247,200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $524,000 | -36.7% | 247,200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $828,000 | +6.7% | 247,200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $776,000 | -2.1% | 247,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $793,000 | +14.3% | 247,200 | +26.1% | 0.00% | -50.0% |
| Q4 2015 | $694,000 | -29.6% | 196,100 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $986,000 | -9.2% | 196,100 | +16.1% | 0.00% | 0.0% |
| Q2 2015 | $1,086,000 | -7.0% | 168,900 | +1.7% | 0.00% | 0.0% |
| Q1 2015 | $1,168,000 | -6.6% | 166,000 | +2.3% | 0.00% | -40.0% |
| Q4 2014 | $1,251,000 | +5.7% | 162,200 | +2.5% | 0.01% | 0.0% |
| Q3 2014 | $1,183,000 | -24.2% | 158,300 | -1.8% | 0.01% | -16.7% |
| Q2 2014 | $1,560,000 | +23.8% | 161,200 | +6.3% | 0.01% | +20.0% |
| Q1 2014 | $1,260,000 | +28.4% | 151,600 | +30.5% | 0.01% | +25.0% |
| Q4 2013 | $981,000 | +5.9% | 116,200 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $926,000 | -2.3% | 116,200 | -5.4% | 0.00% | 0.0% |
| Q2 2013 | $948,000 | – | 122,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |